US Broker Ratings

Legend Biotech Corporation (LEGN) Stock Report: Analysts Predict 204% Upside with Revolutionary CAR-T Therapies

For investors eyeing the healthcare sector, Legend Biotech Corporation (NASDAQ: LEGN) stands out as a compelling opportunity. With a market capitalization of $4.36 billion, the company..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 9.90% Potential Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector as a dynamic player in the drug manufacturing industry, specifically within the specialty and generic..

DaVita Inc. (DVA) Stock Analysis: Exploring the 28% Potential Upside in Healthcare’s Dialysis Leader

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services for patients with chronic kidney failure. Based in Denver,..

Globus Medical, Inc. (GMED) Stock Analysis: A Strong Buy on Impressive 12.63% Potential Upside

Globus Medical, Inc. (NYSE: GMED), a leading player in the medical devices industry, is capturing investor attention with a robust market cap of $12.76 billion and..

Moderna, Inc. (MRNA) Stock Analysis: Insights into its 6.71% Potential Upside Despite Revenue Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to messenger RNA (mRNA) medicines...

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 9.81% Upside in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Venlo, Netherlands, Qiagen is known..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Healthcare Distribution with a $9.42 Billion Market Cap

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare distribution sector, offering a diverse range of products and services that cater to..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 22.84% Potential Upside in Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV) is capturing the attention of investors with its ambitious efforts in the biotechnology sector, despite a challenging financial landscape. Based in..

Option Care Health, Inc. (OPCH) Stock Analysis: A 16% Upside Potential in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the medical care facilities industry, is making waves with its robust growth potential and strategic positioning..

AptarGroup, Inc. (ATR) Stock Analysis: Eyeing a 28.5% Upside with Strong Analyst Support

For investors seeking a compelling opportunity in the healthcare sector, AptarGroup, Inc. (NYSE: ATR) presents a noteworthy case. Known for its innovative solutions in drug delivery..

Agilent Technologies, Inc. (A) Investor Outlook: Potential 13.51% Upside Amid Robust Growth and Solid Buy Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, is making waves with its compelling growth story and favorable analyst ratings. As a..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Promising Biotech with 22% Revenue Growth and Strong Buy Ratings

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has emerged as a significant player in the biotechnology sector, capturing investor attention with its innovative enzyme-based technologies and robust financial..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 52% Potential Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leader in the biotechnology sector, is a company that has caught the attention of investors with its focus on rare..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 9.76% Potential Upside in the Healthcare Sector

Revvity, Inc. (NYSE: RVTY) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $12.12 billion, this..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Revenue Growth Amid High Valuation

Exact Sciences Corporation (NASDAQ: EXAS) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $19.38 billion,..

The Cigna Group (CI) Stock Analysis: Exploring a 17.2% Potential Upside and Robust Analyst Support

The Cigna Group (NYSE: CI), a stalwart in the healthcare industry, presents a compelling investment opportunity with significant potential upside. Operating in the Healthcare Plans industry,..

Mettler-Toledo International, Inc. (MTD): Investor Outlook on Valuation and Growth Potential

Mettler-Toledo International, Inc. (NYSE: MTD) is a prominent player in the healthcare sector, specializing in diagnostics and research. Headquartered in Columbus, Ohio, this company has established..

Viatris Inc. (VTRS) Stock Analysis: Navigating the Opportunities within Healthcare’s Dynamic Landscape

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, operates as a versatile global entity in the drug manufacturing industry. Specializing in both specialty..

Teleflex Incorporated (TFX) Stock Analysis: Navigating the Medical Device Market with a 16.38% Upside Potential

Investors eyeing opportunities in the healthcare sector may find Teleflex Incorporated (NYSE: TFX) an intriguing prospect. As a key player in the medical instruments and supplies..

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring a Potential 19% Upside in the Biotechnology Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology firm, has garnered significant attention in the healthcare sector, particularly among investors seeking growth opportunities in oncology treatments. The..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds